Apr 26, 2024 · we have focused our R&D efforts in antineoplastic drugs, surgery medications, and medicines that treat autoimmune diseases, metabolic diseases ...
Jiangsu Hengrui
Pharmaceutical company
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular... Wikipedia
People also ask
Is dalpiciclib approved in China?
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, develops, manufactures, and commercializes drugs worldwide. The company is developing ...
Jiangsu Hengrui Pharmaceuticals Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, ...
R&D PIPELINE. We established a diversified and comprehensive R&D pipeline covering oncology, autoimmune diseases, pain management, cardiovascular diseases, ...
600276 | Complete Jiangsu Hengrui Medicine Co. Ltd. A stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
An anti-PD-1 immune checkpoint inhibitor camrelizumab for hepatocellular carcinoma; · A nonsteroidal antiandrogen rezvilutamide for prostate cancer; · A PARP ...
Hengrui is a leading global pharmaceutical company headquartered in China with a focus on research, development, manufacturing, and commercialization of ...
Jiangsu Hengrui Medicine Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, surgical.
Jiangsu Hengrui Pharmaceuticals Co.,Ltd develops, manufactures, and markets medicines and medicine packing materials. The Company produces anti-tumor medicines ...
Hengrui Therapeutics, based in Princeton NJ, was founded in 2016 as a $100 million joint venture between Hengrui Medicine and a leading global investment firm, ...